{"transactions":[{"id":3959499,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2018-04-20T22:37:24.000Z","date":"2018-04-18","kind":"grant","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":28125,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001415889-18-000659","document":"form4-04202018_030410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000659/form4-04202018_030410.xml","form_type":"4"}},{"id":4083773,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2018-01-31T22:56:17.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":36558,"price":32.3884,"value":1184055.1272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017 and amended in November 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.37 to $32.45 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":83734,"source":{"system":"sec-edgar","filing":"0001415889-18-000158","document":"form4-01312018_020102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000158/form4-01312018_020102.xml","form_type":"4"}},{"id":4101489,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-11T21:38:26.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":50179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 23, 2013. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":2.18,"expiration_date":"2022-03-22","underlying":"Common Stock","underlying_shares":50179},"source":{"system":"sec-edgar","filing":"0001415889-18-000043","document":"form4-01112018_010112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000043/form4-01112018_010112.xml","form_type":"4"}},{"id":4101488,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2018-01-11T21:38:26.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":50179,"price":2.18,"value":109390.22,"ownership":{"direct":true},"balance_after":120292,"source":{"system":"sec-edgar","filing":"0001415889-18-000043","document":"form4-01112018_010112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000043/form4-01112018_010112.xml","form_type":"4"}},{"id":4108378,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T23:24:30.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":74321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 23, 2013. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":2.18,"expiration_date":"2022-03-22","underlying":"Common Stock","underlying_shares":74321},"source":{"system":"sec-edgar","filing":"0001415889-18-000014","document":"form4-01042018_030117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000014/form4-01042018_030117.xml","form_type":"4"}},{"id":4108377,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2018-01-04T23:24:30.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":74321,"price":30.1414,"value":2240138.9894,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017 and amended in November 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.335 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":70113,"source":{"system":"sec-edgar","filing":"0001415889-18-000014","document":"form4-01042018_030117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000014/form4-01042018_030117.xml","form_type":"4"}},{"id":4108376,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2018-01-04T23:24:30.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":74321,"price":2.18,"value":162019.78,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 457 shares acquired on November 15, 2017 by Mr. Baity under the ACADIA Pharmaceuticals Employee Stock Purchase Plan."}],"balance_after":144434,"source":{"system":"sec-edgar","filing":"0001415889-18-000014","document":"form4-01042018_030117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000014/form4-01042018_030117.xml","form_type":"4"}},{"id":4190373,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the shares subject to the Stock Option vested and became exercisable on October 20, 2010. The remaining shares vested and became exercisable thereafter in 24 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2018-10-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190372,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190371,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 23, 2013. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":124500,"derivative":{"exercise_price":2.18,"expiration_date":"2022-03-22","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190370,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-04","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 23, 2013. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":125500,"derivative":{"exercise_price":2.18,"expiration_date":"2022-03-22","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190369,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-04","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":7500,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190368,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"sale","acquired":false,"shares":37500,"price":40.9078,"value":1534042.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.605 to $41.065 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":69656,"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190367,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":20000,"price":2,"value":40000.0,"ownership":{"direct":true},"balance_after":107156,"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190366,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":7500,"price":1.62,"value":12150.0,"ownership":{"direct":true},"balance_after":99656,"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190365,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":1000,"price":2.18,"value":2180.0,"ownership":{"direct":true},"balance_after":79656,"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190364,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-04","kind":"exercise","acquired":true,"shares":4500,"price":2.18,"value":9810.0,"ownership":{"direct":true},"balance_after":78656,"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4190363,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-10-06T22:20:50.000Z","date":"2017-10-04","kind":"exercise","acquired":true,"shares":6500,"price":1.62,"value":10530.0,"ownership":{"direct":true},"balance_after":74156,"source":{"system":"sec-edgar","filing":"0001415889-17-001636","document":"form4-10062017_031038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001636/form4-10062017_031038.xml","form_type":"4"}},{"id":4213865,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-08T22:15:20.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":46875,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0001415889-17-001472","document":"form4-09082017_030909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001472/form4-09082017_030909.xml","form_type":"4"}},{"id":4219954,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-01T21:15:11.000Z","date":"2017-08-30","kind":"exercise","acquired":false,"shares":16507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":14000,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":16507},"source":{"system":"sec-edgar","filing":"0001415889-17-001447","document":"form4-09012017_020900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001447/form4-09012017_020900.xml","form_type":"4"}},{"id":4219953,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-09-01T21:15:11.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":26507,"price":34.8706,"value":924314.9942,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.87 to $34.88 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":67656,"source":{"system":"sec-edgar","filing":"0001415889-17-001447","document":"form4-09012017_020900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001447/form4-09012017_020900.xml","form_type":"4"}},{"id":4219952,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-09-01T21:15:11.000Z","date":"2017-08-30","kind":"exercise","acquired":true,"shares":16507,"price":1.62,"value":26741.34,"ownership":{"direct":true},"balance_after":94163,"source":{"system":"sec-edgar","filing":"0001415889-17-001447","document":"form4-09012017_020900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001447/form4-09012017_020900.xml","form_type":"4"}},{"id":4236833,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-11T21:38:32.000Z","date":"2017-08-09","kind":"exercise","acquired":false,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":30507,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":13400},"source":{"system":"sec-edgar","filing":"0001415889-17-001378","document":"form4-08112017_020820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001378/form4-08112017_020820.xml","form_type":"4"}},{"id":4236832,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-11T21:38:32.000Z","date":"2017-08-09","kind":"exercise","acquired":false,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":922},"source":{"system":"sec-edgar","filing":"0001415889-17-001378","document":"form4-08112017_020820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001378/form4-08112017_020820.xml","form_type":"4"}},{"id":4236831,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-08-11T21:38:32.000Z","date":"2017-08-09","kind":"sale","acquired":false,"shares":14322,"price":34.8788,"value":499534.1736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.87 to $34.91 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":77656,"source":{"system":"sec-edgar","filing":"0001415889-17-001378","document":"form4-08112017_020820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001378/form4-08112017_020820.xml","form_type":"4"}},{"id":4236830,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-08-11T21:38:32.000Z","date":"2017-08-09","kind":"exercise","acquired":true,"shares":13400,"price":1.62,"value":21708.0,"ownership":{"direct":true},"balance_after":91978,"source":{"system":"sec-edgar","filing":"0001415889-17-001378","document":"form4-08112017_020820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001378/form4-08112017_020820.xml","form_type":"4"}},{"id":4236829,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-08-11T21:38:32.000Z","date":"2017-08-09","kind":"exercise","acquired":true,"shares":922,"price":1.55,"value":1429.1,"ownership":{"direct":true},"balance_after":78578,"source":{"system":"sec-edgar","filing":"0001415889-17-001378","document":"form4-08112017_020820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001378/form4-08112017_020820.xml","form_type":"4"}},{"id":4240474,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-08T22:29:03.000Z","date":"2017-08-04","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":43907,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001415889-17-001348","document":"form4-08082017_030851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001348/form4-08082017_030851.xml","form_type":"4"}},{"id":4240473,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-08-08T22:29:03.000Z","date":"2017-08-04","kind":"exercise","acquired":true,"shares":6500,"price":1.62,"value":10530.0,"ownership":{"direct":true},"balance_after":77656,"source":{"system":"sec-edgar","filing":"0001415889-17-001348","document":"form4-08082017_030851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001348/form4-08082017_030851.xml","form_type":"4"}},{"id":4253431,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-21T21:25:56.000Z","date":"2017-07-20","kind":"exercise","acquired":false,"shares":28097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":28000,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":28097},"source":{"system":"sec-edgar","filing":"0001415889-17-001265","document":"form4-07212017_020745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001265/form4-07212017_020745.xml","form_type":"4"}},{"id":4253430,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-07-21T21:25:56.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":38097,"price":30,"value":1142910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017."}],"balance_after":71156,"source":{"system":"sec-edgar","filing":"0001415889-17-001265","document":"form4-07212017_020745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001265/form4-07212017_020745.xml","form_type":"4"}},{"id":4253429,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-07-21T21:25:56.000Z","date":"2017-07-20","kind":"exercise","acquired":true,"shares":28097,"price":1.62,"value":45517.14,"ownership":{"direct":true},"balance_after":109253,"source":{"system":"sec-edgar","filing":"0001415889-17-001265","document":"form4-07212017_020745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001265/form4-07212017_020745.xml","form_type":"4"}},{"id":4272777,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-26T21:35:31.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":1903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":56097,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":1903},"source":{"system":"sec-edgar","filing":"0001415889-17-001046","document":"form4-06262017_020620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001046/form4-06262017_020620.xml","form_type":"4"}},{"id":4272776,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-06-26T21:35:31.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":1903,"price":30.0004,"value":57090.7612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.01 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":81156,"source":{"system":"sec-edgar","filing":"0001415889-17-001046","document":"form4-06262017_020620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001046/form4-06262017_020620.xml","form_type":"4"}},{"id":4272775,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-06-26T21:35:31.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":1903,"price":1.62,"value":3082.86,"ownership":{"direct":true},"balance_after":83059,"source":{"system":"sec-edgar","filing":"0001415889-17-001046","document":"form4-06262017_020620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001046/form4-06262017_020620.xml","form_type":"4"}},{"id":4316372,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-17T21:42:01.000Z","date":"2017-05-15","kind":"exercise","acquired":false,"shares":14093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":58000,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":14093},"source":{"system":"sec-edgar","filing":"0001415889-17-000785","document":"form4-05172017_020549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000785/form4-05172017_020549.xml","form_type":"4"}},{"id":4316371,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-05-17T21:42:01.000Z","date":"2017-05-15","kind":"exercise","acquired":true,"shares":14093,"price":1.62,"value":22830.66,"ownership":{"direct":true},"balance_after":81156,"source":{"system":"sec-edgar","filing":"0001415889-17-000785","document":"form4-05172017_020549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000785/form4-05172017_020549.xml","form_type":"4"}},{"id":4391102,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-11T01:36:37.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":46875,"derivative":{"exercise_price":36.54,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0001415889-17-000406","document":"form4-03102017_050329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000406/form4-03102017_050329.xml","form_type":"4"}},{"id":4443353,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:05:53.000Z","date":"2017-02-14","kind":"exercise","acquired":false,"shares":6365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on October 22, 2009. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":1.64,"expiration_date":"2018-10-21","underlying":"Common Stock","underlying_shares":6365},"source":{"system":"sec-edgar","filing":"0001415889-17-000281","document":"form4-02162017_040242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000281/form4-02162017_040242.xml","form_type":"4"}},{"id":4443352,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:05:53.000Z","date":"2017-02-14","kind":"exercise","acquired":false,"shares":3224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 7, 2009. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":8.32,"expiration_date":"2018-03-06","underlying":"Common Stock","underlying_shares":3224},"source":{"system":"sec-edgar","filing":"0001415889-17-000281","document":"form4-02162017_040242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000281/form4-02162017_040242.xml","form_type":"4"}},{"id":4443351,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T00:05:53.000Z","date":"2017-02-14","kind":"exercise","acquired":false,"shares":16776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 7, 2009. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":8.32,"expiration_date":"2018-03-06","underlying":"Common Stock","underlying_shares":16776},"source":{"system":"sec-edgar","filing":"0001415889-17-000281","document":"form4-02162017_040242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000281/form4-02162017_040242.xml","form_type":"4"}},{"id":4443350,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-02-17T00:05:53.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":26365,"price":39.6555,"value":1045517.2575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in May 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $39.71 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":67063,"source":{"system":"sec-edgar","filing":"0001415889-17-000281","document":"form4-02162017_040242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000281/form4-02162017_040242.xml","form_type":"4"}},{"id":4443349,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-02-17T00:05:53.000Z","date":"2017-02-14","kind":"exercise","acquired":true,"shares":6365,"price":1.64,"value":10438.6,"ownership":{"direct":true},"balance_after":93428,"source":{"system":"sec-edgar","filing":"0001415889-17-000281","document":"form4-02162017_040242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000281/form4-02162017_040242.xml","form_type":"4"}},{"id":4443348,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-02-17T00:05:53.000Z","date":"2017-02-14","kind":"exercise","acquired":true,"shares":20000,"price":8.32,"value":166400.0,"ownership":{"direct":true},"balance_after":87063,"source":{"system":"sec-edgar","filing":"0001415889-17-000281","document":"form4-02162017_040242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000281/form4-02162017_040242.xml","form_type":"4"}},{"id":4469261,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-03T23:50:59.000Z","date":"2017-02-01","kind":"exercise","acquired":false,"shares":21078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":21078},"source":{"system":"sec-edgar","filing":"0001415889-17-000182","document":"form4-02032017_030250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000182/form4-02032017_030250.xml","form_type":"4"}},{"id":4469260,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-02-03T23:50:59.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":31078,"price":35.1497,"value":1092382.3766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.10 to $35.315 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":67063,"source":{"system":"sec-edgar","filing":"0001415889-17-000182","document":"form4-02032017_030250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000182/form4-02032017_030250.xml","form_type":"4"}},{"id":4469259,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2017-02-03T23:50:59.000Z","date":"2017-02-01","kind":"exercise","acquired":true,"shares":21078,"price":1.55,"value":32670.9,"ownership":{"direct":true},"balance_after":98141,"source":{"system":"sec-edgar","filing":"0001415889-17-000182","document":"form4-02032017_030250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000182/form4-02032017_030250.xml","form_type":"4"}},{"id":4510756,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-29T22:09:47.000Z","date":"2016-12-28","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":72093,"derivative":{"exercise_price":1.62,"expiration_date":"2021-03-24","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001415889-16-007636","document":"form4-12292016_021237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007636/form4-12292016_021237.xml","form_type":"4"}},{"id":4510755,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-29T22:09:47.000Z","date":"2016-12-27","kind":"exercise","acquired":false,"shares":9800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":21078,"derivative":{"exercise_price":1.55,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":9800},"source":{"system":"sec-edgar","filing":"0001415889-16-007636","document":"form4-12292016_021237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007636/form4-12292016_021237.xml","form_type":"4"}},{"id":4510754,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-12-29T22:09:47.000Z","date":"2016-12-28","kind":"exercise","acquired":true,"shares":5500,"price":1.62,"value":8910.0,"ownership":{"direct":true},"balance_after":77063,"source":{"system":"sec-edgar","filing":"0001415889-16-007636","document":"form4-12292016_021237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007636/form4-12292016_021237.xml","form_type":"4"}},{"id":4510753,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-12-29T22:09:47.000Z","date":"2016-12-27","kind":"sale","acquired":false,"shares":9800,"price":30.4565,"value":298473.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $30.60 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":71563,"source":{"system":"sec-edgar","filing":"0001415889-16-007636","document":"form4-12292016_021237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007636/form4-12292016_021237.xml","form_type":"4"}},{"id":4510752,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-12-29T22:09:47.000Z","date":"2016-12-27","kind":"exercise","acquired":true,"shares":9800,"price":1.55,"value":15190.0,"ownership":{"direct":true},"balance_after":81363,"source":{"system":"sec-edgar","filing":"0001415889-16-007636","document":"form4-12292016_021237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007636/form4-12292016_021237.xml","form_type":"4"}},{"id":4514450,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-22T00:03:34.000Z","date":"2016-12-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":30878,"derivative":{"exercise_price":1.55,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-16-007629","document":"form4-12212016_041225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007629/form4-12212016_041225.xml","form_type":"4"}},{"id":4514449,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-22T00:03:34.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":8635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on October 22, 2009. The remaining shares vested and beaome exercisable thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":1.64,"expiration_date":"2018-10-21","underlying":"Common Stock","underlying_shares":8635},"source":{"system":"sec-edgar","filing":"0001415889-16-007629","document":"form4-12212016_041225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007629/form4-12212016_041225.xml","form_type":"4"}},{"id":4514448,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-12-22T00:03:34.000Z","date":"2016-12-20","kind":"sale","acquired":false,"shares":10000,"price":30.0001,"value":300001.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.01 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":71563,"source":{"system":"sec-edgar","filing":"0001415889-16-007629","document":"form4-12212016_041225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007629/form4-12212016_041225.xml","form_type":"4"}},{"id":4514447,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-12-22T00:03:34.000Z","date":"2016-12-20","kind":"exercise","acquired":true,"shares":10000,"price":1.55,"value":15500.0,"ownership":{"direct":true},"balance_after":81563,"source":{"system":"sec-edgar","filing":"0001415889-16-007629","document":"form4-12212016_041225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007629/form4-12212016_041225.xml","form_type":"4"}},{"id":4514446,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-12-22T00:03:34.000Z","date":"2016-12-19","kind":"exercise","acquired":true,"shares":8635,"price":1.64,"value":14161.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7 shares acquired on November 15, 2016 by Mr. Baity under the ACADIA Pharmaceuticals Employee Stock Purchase Plan."}],"balance_after":71563,"source":{"system":"sec-edgar","filing":"0001415889-16-007629","document":"form4-12212016_041225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007629/form4-12212016_041225.xml","form_type":"4"}},{"id":4558545,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-15T00:00:54.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments."}],"balance_after":40878,"derivative":{"exercise_price":1.55,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":10200},"source":{"system":"sec-edgar","filing":"0001415889-16-007417","document":"form4-11142016_041144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007417/form4-11142016_041144.xml","form_type":"4"}},{"id":4558544,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-11-15T00:00:54.000Z","date":"2016-11-10","kind":"sale","acquired":false,"shares":10200,"price":30.0674,"value":306687.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.17 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range."}],"balance_after":62921,"source":{"system":"sec-edgar","filing":"0001415889-16-007417","document":"form4-11142016_041144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007417/form4-11142016_041144.xml","form_type":"4"}},{"id":4558543,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":167410,"kind":"person","name":"Baity Glenn","position":1,"cik":"0001487100","reported_name":"Baity Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GC"}}],"security":"Common Stock","published_at":"2016-11-15T00:00:54.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":10200,"price":1.55,"value":15810.0,"ownership":{"direct":true},"balance_after":73121,"source":{"system":"sec-edgar","filing":"0001415889-16-007417","document":"form4-11142016_041144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588916007417/form4-11142016_041144.xml","form_type":"4"}}]}